The role of stakeholders in the development of ChAdOx1-S COVID-19 vaccine

COVID-19, an infectious disease caused by the virus SARS-CoV-2, has become a global pandemic and has been classified as a Public Health Emergency of International Concern. Considering vaccines as an effective action to shorten viral transmission and to reduce mortality, stakeholders have worked together to develop vaccines, which played a vital role in containing this pandemic worldwide. In the development of the adenovirus-based ChAdOx1-S vaccine, it is interesting to note the speed at which it was created, with safety, breaking paradigms, relying on connections and influences at various levels, showing that a vaccine can be produced in a very short period of time if specific stakeholder dynamics is engaged. Herein, we combined the concepts and methods of Stakeholder Theory and Social Network Analysis within this complex scenario, indeed, the positive results delivered to society reinforce the principles of the Stakeholder Theory. Moreover, Social Network Analysis revealed that the ChAdOx1-S vaccine ecosystem had 30 nodes of interconnection. Overall, the data summarized presently discussed indicate the need for preparedness within the vaccine development ecosystem, important for future research into the management and development process of vaccines designed to cope with future global or regional health emergencies. Key points related to the complexity of a health emergency, considering its risks to public health and society. A coordinated, interdisciplinary, and systemic response between the different actors is emphasized. This study focuses on analyzing the actors involved in the activities related to the development of the ChAdOx1-S vaccine against COVID-19, taking into account the paradigms of time and specificity of the pandemic emergency. Considering the network analysis, for this vaccine, new institutional arrangements have emerged, significantly expanding the limits of knowledge, since the initial research was based on more than a decade of knowledge production.

Authors

Institutions

Publication Details

Journal
Discover Public Health
Published
2024-12-11
DOI
https://doi.org/10.1186/s12982-024-00356-x
Primary Topic
Vaccine Coverage and Hesitancy
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The role of stakeholders in the development of ChAdOx1-S COVID-19 vaccine

Renelson Ribeiro Sampaio, Xisto Lucas Travassos, Wilson Savino, Ana Beatriz Nascimento Ayres et al.
Discover Public Health
Vaccine Coverage and Hesitancy
article

The role of stakeholders in the development of ChAdOx1-S COVID-19 vaccine

Renelson Ribeiro Sampaio, Xisto Lucas Travassos, Wilson Savino, Ana Beatriz Nascimento Ayres, Edla Azevedo Herculano
article en

Abstract

COVID-19, an infectious disease caused by the virus SARS-CoV-2, has become a global pandemic and has been classified as a Public Health Emergency of International Concern. Considering vaccines as an effective action to shorten viral transmission and to reduce mortality, stakeholders have worked together to develop vaccines, which played a vital role in containing this pandemic worldwide. In the development of the adenovirus-based ChAdOx1-S vaccine, it is interesting to note the speed at which it was created, with safety, breaking paradigms, relying on connections and influences at various levels, showing that a vaccine can be produced in a very short period of time if specific stakeholder dynamics is engaged. Herein, we combined the concepts and methods of Stakeholder Theory and Social Network Analysis within this complex scenario, indeed, the positive results delivered to society reinforce the principles of the Stakeholder Theory. Moreover, Social Network Analysis revealed that the ChAdOx1-S vaccine ecosystem had 30 nodes of interconnection. Overall, the data summarized presently discussed indicate the need for preparedness within the vaccine development ecosystem, important for future research into the management and development process of vaccines designed to cope with future global or regional health emergencies. Key points related to the complexity of a health emergency, considering its risks to public health and society. A coordinated, interdisciplinary, and systemic response between the different actors is emphasized. This study focuses on analyzing the actors involved in the activities related to the development of the ChAdOx1-S vaccine against COVID-19, taking into account the paradigms of time and specificity of the pandemic emergency. Considering the network analysis, for this vaccine, new institutional arrangements have emerged, significantly expanding the limits of knowledge, since the initial research was based on more than a decade of knowledge production.

Discover Public HealthVol. 21(1)
Serviço Nacional de Aprendizagem Industrial (BR), Universidade Federal de Santa Catarina (BR), Fundação Oswaldo Cruz (BR)
Bill and Melinda Gates Foundation, GAVI Alliance, AstraZeneca, Deutsches Zentrum für Infektionsforschung, Government of the United Kingdom, UK Research and Innovation, Coalition for Epidemic Preparedness Innovations, SENAI CIMATEC, National Institute for Health and Care Research, Fundação Oswaldo Cruz, Agência Nacional de Vigilância Sanitária, NIHR Oxford Biomedical Research Centre
Zero hunger
Openalex Percentile: Top 70%
Vaccine Coverage and Hesitancy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.